← Back to Search

Procedure

Optimal Ureteral Stent Duration After Surgery

N/A
Waitlist Available
Led By Karen Stern, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-operative day 2-3 and 2-3 days after stent removal
Awards & highlights

Study Summary

This trial studies how soon ureteral stents can be safely removed after surgery.

Who is the study for?
This trial is for individuals who have had a straightforward ureteroscopy, which is a procedure to remove stones from the urinary tract. Participants must be undergoing treatment on one side only, even if they have stones in both sides. Pregnant individuals or those with prior stents, complex procedures, infections, recurrent UTIs, no visible stones during surgery, transplant kidneys or unusual kidney anatomy cannot join.Check my eligibility
What is being tested?
The study aims to find out the safest and soonest time to remove ureteral stents after someone has undergone a ureteroscopy for stone removal. It will help determine optimal recovery practices post-surgery.See study design
What are the potential side effects?
While not explicitly stated here, common side effects of having a ureteral stent include discomfort while urinating, blood in urine, lower back pain on the side of the stented kidney and possibly increased urgency or frequency of urination.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-operative day 2-3 and 2-3 days after stent removal
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-operative day 2-3 and 2-3 days after stent removal for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Urinary Symptom Scores
Secondary outcome measures
Change in Pain Scores
Change in Quality of life
Complications
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Uncomplicated Ureteroscopy and Stent Placement for 7-9 daysExperimental Treatment1 Intervention
After standard of care ureteroscopic procedure stents will be left indwelling for 7-9 days
Group II: Uncomplicated Ureteroscopy and Stent Placement for 3-5 daysActive Control1 Intervention
After standard of care ureteroscopic procedure stents will be left indwelling for 3-5 days
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ureteral stent
2019
N/A
~10

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,207 Previous Clinical Trials
3,766,968 Total Patients Enrolled
Karen Stern, MDPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
90 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

In what locations is this empirical research being conducted?

"This research is taking place in several prestigious institutions, including the University of Arizona in Tucson, California; University of California San Diego in San Diego, Maryland; and Johns Hopkins University in Baltimore, Minnesota. A full list of 11 participating sites can be found elsewhere."

Answered by AI

Are any new participants being sought for this experiment?

"Data available on clinicaltrials.gov confirms that this trial is no longer actively recruiting participants. This research was first posted on September 1, 2023 and last edited 13 days later. Although this study has been concluded for participant recruitment, there are two other trials looking for volunteers at the present moment."

Answered by AI
~69 spots leftby Sep 2024